Ignite Creation Date:
2025-12-25 @ 4:37 AM
Ignite Modification Date:
2026-03-24 @ 6:04 PM
Study NCT ID:
NCT05680818
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-31
First Post:
2022-12-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With ADH1
Sponsor:
Calcilytix Therapeutics, Inc., a BridgeBio company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CLTX-305-302
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None